🇺🇸 FDA
Patent

US 9909188

Methods and compositions involving lincRNA and leukemia

granted A61KA61K31/573

Quick answer

US patent 9909188 (Methods and compositions involving lincRNA and leukemia) held by The Regents of the University of California expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/573